The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1165558
WO Application Number:
GB200001193
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP00920857.0
WO Publication Number:
WO2000058308
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:
Dates
Filing date:
29/03/2000
Grant date:
24/09/2003
EP Publication Date:
24/09/2003
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
24/09/2003
EP B1 Publication Date:
24/09/2003
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
28/03/2020
Lapsed By Expiration Date:
29/03/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
12/11/2014
Name:
Verona Pharma PLC
Address:
One America Square, Croswell, EC3N 2SG, London, United Kingdom (GB)
Historical Applicant/holder
From:
12/11/2014
To:
12/11/2014
Name:
Rhinopharma Limited
Address:
Gerald McGavin Building, suite 101, 2386 East Mall, University of British Colombia, V6T 1Z3, Vancouver, B.C., Canada (CA)